Market Newsdesk

NEW YORK, Nov. 23, 2021 (GLOBE NEWSWIRE) — Latch, Inc. (NASDAQ: LTCH) (“Latch” or the “Company”), maker of LatchOS, the full-building enterprise software-as-a-service (SaaS) platform, today announced it has been named to the inaugural Inc. Best-Led Companies list. To determine the 250 best-led mid-market companies in America, Inc. analyzed 1.3 million data points from more than 10,000 companies.

“At Latch, we take pride in our ability to provide holistic products that transform the way people experience the places they live, work, and visit,” said Luke Schoenfelder, Latch Co-Founder, CEO, and Chairman of the Board of Directors. “The recognition from Inc. is a testament to the hard work, dedication, and focus of our team and our ability to deliver an unmatchable end-user experience for the property owners, operators, and residents we serve.”

The 2021 Inc. Best-Led Companies list recognizes 250 companies that are “agile enough to maneuver, but also big enough to have a broad impact.” To compile the list, Inc. evaluated private and public U.S.-based companies with 2020 revenue of $50 million to $2 billion or a valuation of $50 million to $10 billion using a proprietary 12-point measure of management excellence generated with input from partners at Pitchbook and Shango Labs.

Applicants were analyzed via an algorithm, along with Inc.’s editors, to identify the very best companies according to their leadership teams’ superlative accomplishments in four key areas:

• Performance and value creation
• Market penetration
• Customer engagement
• Talent and leadership team

The full list of Inc. 2021 Best-Led Companies is available here: https://www.inc.com/best-led-companies/2021

About Latch, Inc.

Latch makes spaces better places to live, work, and visit through a system of software, devices, and services. More than one in ten new apartments in the U.S. are currently being built with Latch products, serving customers in more than 43 states through its flagship full-building operating system, LatchOS. For more information, please visit https://www.latch.com.

FORWARD-LOOKING STATEMENTS

This release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding adoption of Latch’s technology and products. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “would,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking information includes, but is not limited to, statements regarding: the Company’s future products, performance, and operations, and the related benefits to shareholders, customers, and residents and the Company’s strategy. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including Latch’s ability to implement business plans and changes and developments in the industry in which Latch competes. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of our Registration Statement on Form S-1 filed with the SEC on June 25, 2021 and other documents filed by Latch from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law, including the securities laws of the United States and the rules and regulations of the SEC. The Company does not give any assurance that it will achieve its expectations.

CONTACTS

Investors
[email protected]

Media
[email protected]

SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the Company will host a Key Opinion Leader (KOL) virtual panel event on smoking and e-cigarette cessation on Thursday, December 2nd, 2021, at 1:00 PM EST.

The event will feature a panel discussion, moderated by healthcare analyst Thomas Flaten of Lake Street Capital Markets, on the importance of smoking and nicotine cessation, with participation from the following esteemed experts in the field of smoking cessation:

• Nancy Rigotti, MD – Professor of Medicine, Harvard Medical School, Director of Tobacco Research & Treatment, Massachusetts General Hospital, and ORCA-2 Principal Investigator
• Neal Benowitz, MD – Professor of Medicine, Emeritus, University of California, San Francisco

Additional details and registration information can be accessed by visiting the Achieve website, http://ir.achievelifesciences.com/events-and-webcasts

About Achieve and Cytisinicline 

Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the United States annually.^1,2 More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.² Achieve’s focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking.

Cytisinicline is an investigational product candidate being developed for treatment of nicotine addiction and has not been approved by the Food and Drug Administration for any indication in the United States. For more information on cytisinicline and Achieve, visit www.achievelifesciences.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development and commercialization activities, the potential market size for cytisinicline, the potential benefits, safety and tolerability of cytisinicline, the ability to discover and develop new uses for cytisinicline, including but not limited to as an e-cigarette cessation product, and the development and effectiveness of new treatments. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking cessation landscape require changes in business strategy or clinical development plans; the risk that Achieve’s intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises and the other factors described in the risk factors set forth in Achieve’s filings with the Securities and Exchange Commission from time to time, including Achieve’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable.

References 
¹ World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization, 2017. 
² U.S. Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress. A Report of the Surgeon General, 2014.  

AUSTIN, Texas, Nov. 23, 2021 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data, and services for brands worldwide, announced today immediate availability of its Multiscreen-as-a-Service (MaaS) platform in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services, Inc. (AWS).

Phunware’s portfolio of Smart Solutions on mobile provides access to all of the features and capabilities of the MaaS platform that any business can license to drive digital transformation through contactless digital access, room-booking, occupancy management, directories, check-in instructions, screenings, feedback tools, news, notifications, analytics, and seamless access and integration to third-party vendors and systems.

“We are thrilled to work with AWS and leverage over a decade of industry experience in order to help enterprises drive digital transformation in a mobile-first world,” said Randall Crowder, Chief Operating Officer at Phunware. “By adding our MaaS Platform to AWS Marketplace, customers around the world can more easily access mobile software that can tech-enable not only critical operations, but also customer and workforce engagement.”

AWS Marketplace
streamlines customer adoption of technology such as MaaS via a consolidated purchase environment and integration with their AWS accounts, which have terms already established. AWS Marketplace SaaS Contracts simplifies the process even further by enabling customers to prepay for MaaS based on expected usage tiers through contracts up to one year in length. The cost of MaaS is integrated into the customer’s AWS bill once they subscribe, resulting in a consolidated, easy-to-process bill.

Click here
to learn more about how MaaS can drive digital transformation.

Safe Harbor Clause and Forward-Looking Statements

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “expose,” “intend,” “may,” “might,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Risk Factors” in our filings with the Securities and Exchange Commission (SEC), including our reports on Forms 10-K, 10-Q, 8-K and other filings that we make with the SEC from time to time. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described under “Risk Factors” in our SEC filings may not be exhaustive.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition, even if our results or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods.

About Phunware, Inc.

Everything You Need to Succeed on Mobile — Transforming Digital Human Experience

Phunware, Inc. (NASDAQ: PHUN)
, is the pioneer of Multiscreen-as-a-Service (MaaS), an award-winning, fully integrated enterprise cloud platform for mobile that provides companies the products, solutions, data and services necessary to engage, manage and monetize their mobile application portfolios and audiences globally at scale. Phunware’s Software Development Kits (SDKs) include location-based services, mobile engagement, content management, messaging, advertising, loyalty (PhunCoin & PhunToken) and analytics, as well as a mobile application framework of pre-integrated iOS and Android software modules for building in-house or channel-based mobile application and vertical solutions. Phunware helps the world’s most respected brands create category-defining mobile experiences, with approximately one billion active devices touching its platform each month when operating at scale. For more information about how Phunware is transforming the way consumers and brands interact with mobile in the virtual and physical worlds, visit https://phunware.com, https://phunwallet.com, https://phuncoin.com, https://phuntoken.com, and follow @phunware, @phuncoin and @phuntoken on all social media platforms.

Phunware PR & Media Inquiries:

[email protected]

T: (512) 693-4199

Phunware Investor Relations:

Matt Glover and John Yi
Gateway Investor Relations
Email: [email protected]
Phone: (949) 574-3860

MELVILLE, N.Y., Nov. 23, 2021 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity, disaster recovery protection, IBM Power infrastructure-as-a-service and cyber-security based solutions, today announced that Chuck Piluso, Chairman and CEO of Data Storage Corporation will be participating in the Benzinga All Access event taking place on December 2, 2021 at 10:00 AM Eastern Time.

The event will be broadcast live and can be viewed here. An archived recording of the presentation will be available on the investor relations section of the Company’s website at IR.DataStorageCorp.com.

About Benzinga All Access

Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. On All Access, Benzinga partners with companies to bring you in-depth one-on-one conversations with executives across a wide range of industries and asset classes. From emerging biotechs, to alternative real estate investment platforms, to everything in between, guests on All Access have one thing in common: they want to tell their story to investors.

About Data Storage Corporation

The Company provides a broad range of premium technology solutions focusing on IaaS, data protection and IT management. Clients look to Data Storage to ensure disaster recovery, business continuity, enhance security, and to meet increasing industry, state and federal regulations. The Company markets to businesses, government, education and the healthcare industry by leveraging leading technologies. Through its business units, the Company provides IaaS, SaaS, DRaaS, VoIP, cyber security, data analytics, IBM Power systems and storage hardware with managed IT services. For more information, please visit http://www.DataStorageCorp.com.

Contact:

Crescendo Communications, LLC
212-671-1020
[email protected]

SOURCE: Data Storage Corporation

PLEASANTON, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ: WDAY), a leader in enterprise cloud applications for finance and human resources, today announced that Robynne Sisco, co-president and chief financial officer of Workday, will present virtually at Wells Fargo Fifth Annual TMT Summit on Tuesday, Nov. 30, at 11:40 a.m. Pacific Time / 2:40 p.m. Eastern Time. Individuals may access the live webcast of the presentation here.

In addition, Doug Robinson, co-president, Workday, will present virtually at Barclays Global TMT Conference on Tuesday, Dec. 7, at 6:10 a.m. Pacific Time / 9:10 a.m. Eastern Time. Individuals may access the live webcast of the presentation here.

A replay of each presentation will be available on the Workday Investor Relations site for a minimum of 30 days after the conferences take place.

About Workday


Workday
is a leading provider of enterprise cloud applications for finance and human resources, helping customers adapt and thrive in a changing world. Workday applications for financial management, human resources, planning, spend management, and analytics have been adopted by thousands of organizations around the world and across industries—from medium-sized businesses to more than 50% of the Fortune 500. For more information about Workday, visit workday.com.

© 2021 Workday, Inc. All rights reserved. Workday and the Workday logo are registered trademarks of Workday, Inc. All other brand and product names are trademarks or registered trademarks of their respective holders.

Investor Relations Contact:

Justin Furby
[email protected]

Media Contact:

Courtney Laub
[email protected]

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following virtual investor conferences in December:

4th Annual Evercore ISI HealthCONx Conference

Date: Wednesday, December 1, 2021
Time: 12:35 p.m. ET

Piper Sandler 33rd Annual Healthcare Conference

Date: Thursday, December 2, 2021
Time: 1:00 p.m. ET

A live webcast of the events will be available on the “Events & Presentations” page in the Investors section of the Company’s website at https://crisprtx.gcs-web.com/events. A replay of the webcasts will be archived on the Company’s website for 14 days following each presentation.

About CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

CRISPR THERAPEUTICS^® word mark and design logo are trademarks and registered trademarks of CRISPR Therapeutics AG. All other trademarks and registered trademarks are the property of their respective owners.

Investor Contact:

Susan Kim
+1-617-307-7503
[email protected]

Media Contact:

Rachel Eides
+1-617-315-4493
[email protected]

BOCA RATON, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in November and December 2021:

Cowen 4

^th

Annual Cannabis Conference

Date: Monday, November 29^th through Wednesday, December 1^st  
Where: Virtual panel presentation and 1×1 meetings
Panel: Tuesday, November 30^th at 11:50 a.m. Eastern time

CannaVest West Institutional Capital Forum

Date: Thursday, December 16^th through Friday, December 17^th
Where: Moscone Center, San Francisco, CA
Panel: Friday, December 17^th at 2:15 p.m. Eastern time
Agenda and Registration: https://cv.thecannabisindustry.org/

For more information about the conferences or to schedule a 1-on-1 meeting with Clever Leaves management, please contact your respective conference representative or contact the Company’s investor relations team at [email protected].

About Clever Leaves Holdings Inc.

Clever Leaves is a multinational cannabis company with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade cannabinoid processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collecting Practices (GACP) Certification. Clever Leaves was granted a license in Portugal from Infarmed – the Portuguese health authority – which allows Clever Leaves to cultivate, import and export dry flower for medicinal and research purposes. In addition, the Portuguese operation was also granted certification of compliance with GACP and IMC-GAP.

Clever Leaves Investor Inquiries:

Cody Slach or Jackie Keshner
Gateway Investor Relations
+1-949-574-3860
[email protected]

Clever Leaves Press Contacts:

McKenna Miller
KCSA Strategic Communications
+1-347-487-6197
[email protected]

Diana Sigüenza
Strategic Communications Director
+57-310-236-8830
[email protected]

Clever Leaves Commercial Inquiries:

Andrew Miller
Vice President Sales – EMEA, North America, and Asia-Pacific
+1-416-817-1336
[email protected]

Project Change Lives Inquiries:

[email protected]

WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based marketing technology software provider, announced today a new partnership with Optimizely, a leader in the IDC Marketscape for B2B Commerce.

Optimizely will use Bridgeline’s Hawksearch platform to grow their B2B customer’s online revenue with AI-powered product search. Hawksearch will be the first fully integrated, out-of-the-box search vendor in the Optimizely B2B Commerce admin console.

Hawksearch’s partnerships include Salesforce B2B Commerce, BigCommerce, Magento, and Progress Sitefinity.   

“When looking for a search partner, Hawksearch quickly distinguished itself as a leader in the B2B search space. Optimizely was quick to recognize how our B2B customers could benefit from this partnership, and we are excited to have Hawksearch pre-integrated and available directly in the admin console,” said Optimizely’s Senior Director of Strategy and Commerce, Josh Shoonmaker.

The CEO of Bridgeline, Ari Kahn, says, “We are proud to be the first out-of-the-box connector for the Optimizely B2B Commerce Cloud and we expect to help Optimizely-powered web sites grow revenue.”

Click here to read Optimizely’s statement.

About Bridgeline Digital

Bridgeline helps companies grow online revenues by increasing their traffic, conversion rates, and average order values. To learn more, please visit www.bridgeline.com.

Contact:

Danielle Erwin

VP of Marketing

Bridgeline Digital

[email protected]

‍